Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

OBJECTIVES: To compare the real-world effectiveness of newer disease-modifying therapies (DMTs) vs injectables in children with relapsing-remitting multiple sclerosis (RRMS). METHODS: In this retrospective, multicenter study, from the UK Childhood Inflammatory Demyelination Network, we identified ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-mannan, Omar A., Manchoon, Celeste, Rossor, Thomas, Southin, Justine-Clair, Tur, Carmen, Brownlee, Wallace, Byrne, Susan, Chitre, Manali, Coles, Alasdair, Forsyth, Rob, Kneen, Rachel, Mankad, Kshitij, Ram, Dipak, West, Siobhan, Wright, Sukhvir, Wassmer, Evangeline, Lim, Ming, Ciccarelli, Olga, Hemingway, Cheryl, Hacohen, Yael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143699/
https://www.ncbi.nlm.nih.gov/pubmed/34021056
http://dx.doi.org/10.1212/NXI.0000000000001008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143699/
https://www.ncbi.nlm.nih.gov/pubmed/34021056
http://dx.doi.org/10.1212/NXI.0000000000001008

Ejemplares similares